Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−38.30 SEK
−29.19 M SEK
976.28 K SEK
About CHORDATE MEDICAL HOLDING AB
Sector
CEO
Anders Henrik Weilandt
Headquarters
Kista
Website
Founded
2014
ISIN
SE0022726139
FIGI
BBG00KVZ6TS3
Chordate Medical Holding AB is a medical technology company. It engages in the provision of developed, patented, and CE-marked product systems for neurostimulation treatment for the indications chronic migraine and chronic nasal congestion. The company was founded in February 2014 and is headquartered in Kista, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CMH is 8.98 SEK — it has decreased by −2.60% in the past 24 hours. Watch CHORDATE MEDICAL HOLDING AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CHORDATE MEDICAL HOLDING AB stocks are traded under the ticker CMH.
CMH stock has fallen by −28.45% compared to the previous week, the month change is a −52.36% fall, over the last year CHORDATE MEDICAL HOLDING AB has showed a −89.26% decrease.
CMH stock is 5.22% volatile and has beta coefficient of −0.51. Track CHORDATE MEDICAL HOLDING AB stock price on the chart and check out the list of the most volatile stocks — is CHORDATE MEDICAL HOLDING AB there?
Today CHORDATE MEDICAL HOLDING AB has the market capitalization of 9.95 M, it has decreased by −20.78% over the last week.
Yes, you can track CHORDATE MEDICAL HOLDING AB financials in yearly and quarterly reports right on TradingView.
CHORDATE MEDICAL HOLDING AB is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
CMH net income for the last quarter is −5.68 M SEK, while the quarter before that showed −7.02 M SEK of net income which accounts for 19.11% change. Track more CHORDATE MEDICAL HOLDING AB financial stats to get the full picture.
No, CMH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 3.00 employees. See our rating of the largest employees — is CHORDATE MEDICAL HOLDING AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHORDATE MEDICAL HOLDING AB EBITDA is −26.54 M SEK, and current EBITDA margin is −2.91 K%. See more stats in CHORDATE MEDICAL HOLDING AB financial statements.
Like other stocks, CMH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHORDATE MEDICAL HOLDING AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHORDATE MEDICAL HOLDING AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHORDATE MEDICAL HOLDING AB stock shows the sell signal. See more of CHORDATE MEDICAL HOLDING AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.